I’m not sure how many people with Still’s Disease are treated with Orencia (Abatacept) compared to other available drugs but since this is next in line for me I’ve requested alerts to any articles that may be relevant.
This news, received yesterday, seems promising for those who do take it, as a new injectable version of the drug could soon be approved. Currently, you need to receive Orencia via monthly infusion at the hospital or a more local health centre if one is available. For the majority of people, I would guess that this is a small price to pay for being well, but there will be some who find the trip impractical and would much prefer access to it within their own homes. Of course, the other bonus is that it frees up space and money taken up by treating patients in hospital on such a regular basis, rather than the more distant support you receive while taking home injectables such as Enbrel and Anakinra.
It would probably mean the waiting time to start would be less too, which would have suited me fine!